TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency

Abstract Progranulin is a pro-protein that is necessary for maintaining lysosomal function. Loss-of-function progranulin (GRN) mutations are a dominant cause of frontotemporal dementia (FTD). Brains of people with FTD due to GRN mutations accumulate lysosomal storage material and exhibit increased e...

Full description

Saved in:
Bibliographic Details
Main Authors: Wren O. Nader, Kaylan S. Brown, Nicholas R. Boyle, Azariah K. Kaplelach, Shaimaa M. Abdelaziz, Skylar E. Davis, Qays Aljabi, Ahmad R. Hakim, Amelia G. Davidson, Giacynta A. Vollmer, Leah C. Wright, J. Bailey Echols, Joelle Saad, Nicholas S. Pena, Andrew E. Arrant
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-12268-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342523057635328
author Wren O. Nader
Kaylan S. Brown
Nicholas R. Boyle
Azariah K. Kaplelach
Shaimaa M. Abdelaziz
Skylar E. Davis
Qays Aljabi
Ahmad R. Hakim
Amelia G. Davidson
Giacynta A. Vollmer
Leah C. Wright
J. Bailey Echols
Joelle Saad
Nicholas S. Pena
Andrew E. Arrant
author_facet Wren O. Nader
Kaylan S. Brown
Nicholas R. Boyle
Azariah K. Kaplelach
Shaimaa M. Abdelaziz
Skylar E. Davis
Qays Aljabi
Ahmad R. Hakim
Amelia G. Davidson
Giacynta A. Vollmer
Leah C. Wright
J. Bailey Echols
Joelle Saad
Nicholas S. Pena
Andrew E. Arrant
author_sort Wren O. Nader
collection DOAJ
description Abstract Progranulin is a pro-protein that is necessary for maintaining lysosomal function. Loss-of-function progranulin (GRN) mutations are a dominant cause of frontotemporal dementia (FTD). Brains of people with FTD due to GRN mutations accumulate lysosomal storage material and exhibit increased expression of lysosomal transcripts, which may be driven by TFEB and related transcription factors. While this may be a compensatory response to lysosomal impairment, overproduction of lysosomal proteins may also contribute to FTD pathogenesis. To investigate how TFEB may contribute to disease in people with GRN mutations, we analyzed the effects of TFEB overexpression in progranulin-insufficient cells and mice. We generated GRN knockout HEK-293 cells (GRN KO cells), which exhibited increased nuclear localization of TFEB and expression of lysosomal transcripts, but impaired autophagy. TFEB overexpression in GRN KO cells further increased lysosomal transcripts and partially normalized autophagy. We next injected an AAV vector expressing mouse Tfeb (AAV-TFEB) into the thalamus of Grn –/– mice, which accumulates lysosomal storage material. AAV-TFEB increased lysosomal transcripts and reduced immunoreactivity for SCMAS, a marker of lysosomal storage material, in Grn –/– thalamus. These data show that TFEB activity alleviates some autophagy-lysosomal deficits caused by progranulin insufficiency, suggesting potential utility of lysosome-based therapies for GRN-associated diseases.
format Article
id doaj-art-85d274bca1904cec86991292dbeb060d
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-85d274bca1904cec86991292dbeb060d2025-08-20T03:43:21ZengNature PortfolioScientific Reports2045-23222025-07-0115111410.1038/s41598-025-12268-0TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiencyWren O. Nader0Kaylan S. Brown1Nicholas R. Boyle2Azariah K. Kaplelach3Shaimaa M. Abdelaziz4Skylar E. Davis5Qays Aljabi6Ahmad R. Hakim7Amelia G. Davidson8Giacynta A. Vollmer9Leah C. Wright10J. Bailey Echols11Joelle Saad12Nicholas S. Pena13Andrew E. Arrant14Killion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamKillion Center for Neurodegeneration and Experimental Therapeutics, Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at BirminghamAbstract Progranulin is a pro-protein that is necessary for maintaining lysosomal function. Loss-of-function progranulin (GRN) mutations are a dominant cause of frontotemporal dementia (FTD). Brains of people with FTD due to GRN mutations accumulate lysosomal storage material and exhibit increased expression of lysosomal transcripts, which may be driven by TFEB and related transcription factors. While this may be a compensatory response to lysosomal impairment, overproduction of lysosomal proteins may also contribute to FTD pathogenesis. To investigate how TFEB may contribute to disease in people with GRN mutations, we analyzed the effects of TFEB overexpression in progranulin-insufficient cells and mice. We generated GRN knockout HEK-293 cells (GRN KO cells), which exhibited increased nuclear localization of TFEB and expression of lysosomal transcripts, but impaired autophagy. TFEB overexpression in GRN KO cells further increased lysosomal transcripts and partially normalized autophagy. We next injected an AAV vector expressing mouse Tfeb (AAV-TFEB) into the thalamus of Grn –/– mice, which accumulates lysosomal storage material. AAV-TFEB increased lysosomal transcripts and reduced immunoreactivity for SCMAS, a marker of lysosomal storage material, in Grn –/– thalamus. These data show that TFEB activity alleviates some autophagy-lysosomal deficits caused by progranulin insufficiency, suggesting potential utility of lysosome-based therapies for GRN-associated diseases.https://doi.org/10.1038/s41598-025-12268-0ProgranulinTFEBLysosomesAutophagy
spellingShingle Wren O. Nader
Kaylan S. Brown
Nicholas R. Boyle
Azariah K. Kaplelach
Shaimaa M. Abdelaziz
Skylar E. Davis
Qays Aljabi
Ahmad R. Hakim
Amelia G. Davidson
Giacynta A. Vollmer
Leah C. Wright
J. Bailey Echols
Joelle Saad
Nicholas S. Pena
Andrew E. Arrant
TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
Scientific Reports
Progranulin
TFEB
Lysosomes
Autophagy
title TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
title_full TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
title_fullStr TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
title_full_unstemmed TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
title_short TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
title_sort tfeb overexpression alleviates autophagy lysosomal deficits caused by progranulin insufficiency
topic Progranulin
TFEB
Lysosomes
Autophagy
url https://doi.org/10.1038/s41598-025-12268-0
work_keys_str_mv AT wrenonader tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT kaylansbrown tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT nicholasrboyle tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT azariahkkaplelach tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT shaimaamabdelaziz tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT skylaredavis tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT qaysaljabi tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT ahmadrhakim tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT ameliagdavidson tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT giacyntaavollmer tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT leahcwright tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT jbaileyechols tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT joellesaad tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT nicholasspena tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency
AT andrewearrant tfeboverexpressionalleviatesautophagylysosomaldeficitscausedbyprogranulininsufficiency